The Leadership Team at Pulmatrix plays a pivotal role in guiding the company’s strategic direction and operational execution in the development of innovative inhaled therapies. Composed of key executives, including the Chief Medical Officer and Vice Presidents of Quality and CMC & Pharmaceutical Development, they collaborate to ensure that clinical, regulatory, and manufacturing objectives align with the company’s mission to address respiratory diseases like cystic fibrosis and COPD. Their expertise drives decision-making, resource allocation, and fosters a culture of excellence within the organization.
View all